| P50 | author | Timothy Synold | Q78536675 |
| P2093 | author name string | Elizabeth Eisenhauer | |
| | Lesley Seymour | |
| | Jennifer J Knox | |
| | Ron Feld | |
| | Sharlene Gill | |
| | James J Biagi | |
| | Pierre Major | |
| | Christine Cripps | |
| | Nancy Wainman | |
| P2860 | cites work | Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis | Q44670527 |
| | Phase II study of capecitabine in patients with fluorouracil-resistant metastatic colorectal carcinoma | Q44915310 |
| | Prospective Validation of the Cancer of the Liver Italian Program(CLIP) Score: A New Prognostic System for Patients With Cirrhosis and Hepatocellular Carcinoma | Q58022059 |
| | Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial | Q58236593 |
| | Liver transplantation for hepatocellular carcinoma | Q73075761 |
| | Rising incidence of hepatocellular carcinoma in the United States | Q74595692 |
| | Global cancer statistics, 2002 | Q27860562 |
| | New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 |
| | Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival | Q29616865 |
| | The way things move: looking under the hood of molecular motor proteins | Q29617532 |
| | The study of innate drug resistance of human hepatocellular carcinoma Bel7402 cell line | Q33177639 |
| | Past and future of the mitotic spindle as an oncology target | Q34441105 |
| | Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. | Q34714683 |
| | Are there indications for chemotherapy in hepatocellular carcinoma? | Q35123001 |
| | Pharmacotherapy of hepatocellular carcinoma | Q35593957 |
| | Activation of multidrug resistance (P-glycoprotein) mdr3/mdr1a gene during the development of hepatocellular carcinoma in hepatitis B virus transgenic mice | Q41112054 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Canada | Q16 |
| | pharmacokinetics | Q323936 |
| | metastatic hepatocellular carcinoma | Q108607261 |
| | phase II clinical trial | Q42824440 |
| P304 | page(s) | 265-272 | |
| P577 | publication date | 2008-01-15 | |
| P1433 | published in | Investigational New Drugs | Q2312231 |
| P1476 | title | A phase II and pharmacokinetic study of SB-715992, in patients with metastatic hepatocellular carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG IND.168) | |
| P478 | volume | 26 | |